Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Colby who wrote (8647)	5/28/1998 4:28:00 PM
From: Anthony Ostroski	Respond to of 23519

hope for 11 instead

To: Colby who wrote (8647)	5/28/1998 9:26:00 PM
From: Richard Singer	Respond to of 23519

Colby: Excellent post! Richard

To: Colby who wrote (8647)	5/28/1998 10:38:00 PM
From: Frostman	Read Replies (1) \| Respond to of 23519

Colby, Yes, like Richard said, Great post! <<This stock has always had a tremendous short position and will for some time, unless Viagra falls fo the planet. The company has a lot to prove and until it does, I am not expecting any drastic changes in the short position.>> A lot to prove for sure. Perhaps the FDA approval won't provide much proof, or a nice pop, in and of itself. A friend reminded me tonight that in one of the many recent Viagra articles, Vivus was mentioned as being a strong upgrade candidate when the FDA approval is announced. Long-money already believes the script numbers will be rewarding as the ED market continues to grow and is sorted out. Even with the goofy low volume today, Worden's service indicates that VVUS is under heavy accumulation with folks buying and holding. So, the stage is set. We've been living in the shadow of the "short position" for so long without the big squeeze, I've become immune to the concept. Big deal. Frostman